Biocept Signs CNSide™ Licensing Agreement
VIP LIVEALERTS-PRO Biocept Signs CNSide™ Licensing Agreement Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics September 08, 2023 08:00 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) […]
Taysha gene therapies reports initial clinical data
VIP LIVEALERTS-PRO Taysha Gene Therapies, Inc Taysha gene therapies reports initial clinical data from first adult rett syndrome patient dosed in reveal phase 1/2 trial and provides corporate update with second quarter 2023 financial results Data from first adult patient dosed in REVEAL Phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent serious adverse […]
Missfresh Announces Entry of Share Purchase Agreements
VIP LIVEALERTS-PRO Missfresh Share Purchase Agreements Missfresh Announces Entry of Share Purchase Agreements for Financing and Business Acquisition BEIJING, Aug. 03, 2023 (GLOBE NEWSWIRE) — Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF), today announced that it entered into two share purchase agreements with two investors, respectively (the “Share Purchase Agreements for Financing”), and another […]
Kidpik Teams Up with Disney
VIP LIVEALERTS-PRO Kidpik Teams Up with Disney Kidpik Teams Up with Disney to Celebrate the Release of Disney+ Original Movie “World’s Best” NEW YORK, June 23, 2023 /PRNewswire/ — Kidpik Corp. (NASDAQ: PIK) (“Kidpik” or the “Company”) announces a fun collaboration surrounding the release of “World’s Best,” a new film now streaming exclusively on Disney+ (subscription required). In […]
Walgreens Boots Alliance Sells Remaining Shares
VIP LIVEALERTS-PRO Walgreens Boots Alliance Walgreens Boots Alliance Sells Remaining Shares of Option Care Health for Approximately $330 Million of Proceeds Transaction Highlights Walgreens Boots Alliance announces the sale of its remaining shares of Option Care Health for proceeds of approximately $330 million Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown, […]
Apple Vision Pro: Apple’s first spatial computer
VIP LIVEALERTS-PRO Apple Vision Pro™ Introducing Apple Vision Pro: Apple’s first spatial computer Introducing the era of spatial computing with Apple Vision Pro. (Photo: Business Wire) June 05, 2023 03:03 PM Eastern Daylight Time CUPERTINO, Calif.-(BUSINESS WIRE)-Apple® today unveiled Apple Vision Pro™, a revolutionary spatial computer that seamlessly blends digital content with the physical world, […]
App Store developers generated $1.1 trillion
VIP LIVEALERTS-PRO App Store developers generated $1.1 trillion App Store developers generated $1.1 trillion in total billings and sales in the App Store ecosystem in 2022 More than 90 percent of billings and sales accrued solely to developers, without any commission paid to Apple New study underscores the strength and resilience of the App Store […]
Microbot Medical Achieved 100% Success Rate for LIBERTY
VIP LIVEALERTS-PRO Microbot Medical Achieved 100% Success Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations May 22, 2023 08:30 ET| Source: Microbot Medical Inc HINGHAM, […]
Sunshine Biopharma Reports 2023 First Quarter: Revenues Up 2,100%
VIP LIVEALERTS-PRO Sunshine Biopharma Revenues Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100% MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2023 first quarter report. […]
Aclarion skyrockets 197% after positive trial data
VIP LIVEALERTS-PRO Aclarion Groundbreaking Clinical Trial Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial Apr. 24, 2023 7:00 AM ET Source: Aclarion, Inc. Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with Nociscan-identified discs, a 22 percentage point improvement over patients whose […]